Syros Pharmaceuticals, Inc. (SYRS) Interest Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2024.
  • Syros Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $1.31 M, a 7.4% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $5.22 M, a 19.2% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2023 was $5.13 M, a 24% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13 M, a 5.81% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2021 was $3.91 M, a 118% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.22 M $1.31 M +$90 K +7.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.13 M $1.33 M +$203 K +18% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $4.92 M $1.3 M +$252 K +24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.67 M $1.28 M +$297 K +30.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.38 M $1.22 M +$241 K +24.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $4.13 M $1.13 M +$139 K +14.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $4 M $1.05 M +$67 K +6.81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.93 M $981 K +$12 K +1.24% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.92 M $976 K +$9 K +0.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.91 M $987 K +$446 K +82.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.46 M $984 K +$491 K +99.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.97 M $969 K +$482 K +99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.49 M $967 K +$696 K +257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.79 M $541 K +$521 K +2605% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 $1.27 M $493 K +$472 K +2248% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $799 K $487 K +$464 K +2017% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $335 K $271 K +$263 K +3288% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $72 K $20 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $21 K Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 $23 K Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 $8 K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.